Ikena Oncology, Inc.
NASDAQ:IKNA
17.16 (USD) • At close July 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 9.16 | 15.618 | 30.985 | 9.194 | 13.753 | 0.99 |
| Cost of Revenue
| 0.49 | 1.02 | 64.321 | 47.108 | 44.847 | 24.938 | 38.986 |
| Gross Profit
| -0.49 | 8.14 | 13.584 | -16.123 | -35.653 | -11.185 | -37.996 |
| Gross Profit Ratio
| 0 | 0.889 | 0.87 | -0.52 | -3.878 | -0.813 | -38.38 |
| Reseach & Development Expenses
| 30.385 | 59.652 | 64.321 | 47.108 | 44.847 | 24.938 | 38.564 |
| General & Administrative Expenses
| 23.679 | 24.925 | 22.201 | 18.015 | 8.866 | 7.307 | 2.898 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 23.679 | 24.925 | 22.201 | 18.015 | 8.866 | 7.307 | 2.898 |
| Other Expenses
| 0 | -1.02 | -2.034 | -47.108 | -44.847 | 0 | 0 |
| Operating Expenses
| 54.064 | 83.557 | 84.488 | 18.015 | 8.866 | 32.245 | 41.462 |
| Operating Income
| -58.973 | -75.417 | -70.904 | -34.138 | -44.519 | -18.492 | -40.894 |
| Operating Income Ratio
| 0 | -8.233 | -4.54 | -1.102 | -4.842 | -1.345 | -41.307 |
| Total Other Income Expenses Net
| 9.891 | 7.089 | 2.139 | 0.023 | 0.263 | 1.675 | 0.029 |
| Income Before Tax
| -49.082 | -68.328 | -68.765 | -34.115 | -44.256 | -16.817 | -40.865 |
| Income Before Tax Ratio
| 0 | -7.459 | -4.403 | -1.101 | -4.814 | -1.223 | -41.278 |
| Income Tax Expense
| 0.152 | -0.162 | -2.139 | 0.307 | 0 | 0.071 | 0 |
| Net Income
| -49.234 | -68.166 | -68.765 | -34.115 | -44.256 | -16.817 | -40.865 |
| Net Income Ratio
| 0 | -7.442 | -4.403 | -1.101 | -4.814 | -1.223 | -41.278 |
| EPS
| -1.02 | -1.63 | -1.9 | -0.95 | -1.23 | -0.47 | -1.14 |
| EPS Diluted
| -1.02 | -1.63 | -1.9 | -0.95 | -1.23 | -0.47 | -1.14 |
| EBITDA
| -48.592 | -74.397 | -70.153 | -33.594 | -44.219 | -18.249 | -40.443 |
| EBITDA Ratio
| 0 | -8.122 | -4.492 | -1.084 | -4.81 | -1.327 | -40.852 |